French validation of the Weight Efficacy Life-Style questionnaire (WEL): Links with mood, self-esteem and stress among the general population and a clinical sample of individuals with overweight and obesity.

Eating self-efficacy refers to a person's belief in their ability to regulate eating. Although the Weight Efficacy Life-Style questionnaire (WEL) is one of the most widely used eating self-efficacy tools, its French validation is lacking. The objective of this research was to validate a French version of the WEL in a general and a clinical sample, and to explore the links between eating self-efficacy and psychosocial variables. In study 1, the general population sample included 432 adults (93% of women, mean age = 43.18 ± 11.93 years). In study 2, the clinical sample included 2010 adults with overweight and obesity (87% of women, mean age = 44.44 ± 11.25 years). Exploratory and confirmatory factor analyses were performed. Two distinct versions of the WEL were retained: a 12-item questionnaire intended for use in the general population, named WEL-Fr-G, and an 11-item questionnaire for clinical samples, named WEL-Fr-C. The two French versions of the WEL presented strong reliability and sensibility. In addition, study 2 provided support for the measurement invariance of the WEL-Fr-C across sex and Body Mass Index. The two versions are therefore psychometrically sound instruments for assessing eating self-efficacy in the general population (WEL-Fr-G) and clinical samples (WEL-Fr-C).

1. Introduction

Obesity is defined by the World Health Organization (WHO) as "the abnormal or excessive fat accumulation that presents a risk to health" [1]. Overweight and obesity constitute a major risk factor for the onset of severe health complications such as cardiovascular and respiratory diseases, diabetes and some types of cancers [1, 2], hence making it one of the major challenges for public health on a global scale. In France, nearly 50% of the adult population was overweight or suffered from obesity in 2015 [3]. The main cause of overweight and obesity relies in an energy imbalance between caloric intake and expenditure [4-6]. Reasons behind this imbalance are various and include individual’s lifestyle [6, 7], physiological causes (such as the microbiome [8] or sleep duration [9, 10]) but also individual’s socio-economic situation [11], obesogenic environments such as the proximity to fast-food restaurants or a gym [12-15], genetics [16] and even air pollution [17]. Numerous psychological factors of obesity were identified as well [5]. Yet, treatment that is mostly offered to patients suffering from obesity consists of life style changes embodying the adoption of healthy eating habits and increased physical activity [18-20]. Long-term follow-up evaluations revealed that behavioural interventions, promotion of healthier eating habits and increased physical activity are not effective in treating obesity over the long term. Researchers therefore began to explore psychosocial predictors of weight regain and barriers to weight maintenance. Results from previous studies identified various behavioural correlates, such as dietary intake and physical activity as well as diverse psychological correlates, such as psychological distress, low well-being, binge-eating disorder, body dissatisfaction, low self-esteem or low quality of life [21-25]. More precisely, some authors have identified self-efficacy as one of the variables that predicts long-term behaviour change [26].

Self-efficacy is the key component of Bandura’s social cognitive theory defined as individual’s confidence in their ability to perform and succeed in certain situations [27, 28]. Self-efficacy is domain-specific and is, therefore, found to be a predictor of behaviours such as academic performance [29], shift to electric vehicles in Chinese adults [30] and also health behaviours like tobacco dependence [31], substance use disorders [32], diabetes-related care [33, 34], asthma self-management [35] and exercise [36]. Self-efficacy plays an important role in many theories of health behaviour change, including the Trans theoretical Model [37] and the Health Belief Model [38], because it motivates behaviour and predicts its initiation. Weight related self-efficacy is considered an important psychological factor of weight management as it predicts weight loss, weight maintenance and dietary intake. More specifically, eating self-efficacy (ESE), defined by Clark et al. [39] as the ability of individuals to resist their desire to eat in different situations, was found to predict dietary behaviour [40, 41]. Indeed, ESE was positively related to increased fruit and vegetable consumption [42-45] and negatively related to saturated fat and fast food consumption [44, 46]. ESE was also identified as a mediator between social support and dietary intake in low-income women [43, 46, 47] as well as a moderator between intention and eating behaviour [41]. Not surprisingly, ESE was also linked to weight loss [48]. However, the reported results are conflicting. While numerous authors have identified ESE as a predictor of weight loss [18, 45, 49–53], some authors have found opposite results: ESE at baseline was not a predictor of weight loss [54, 55]. Some studies have shown that higher ESE levels before weight loss management predicted lower weight loss, which can be interpreted as overconfidence on the part of the patient, leading to disruption of the weight loss attempt [45, 56]. However, changes in ESE, due to the weight loss treatment in which the participants were enrolled, may be a more significant predictor of weight loss than ESE at baseline [45, 54–55]. Based on the results of previous studies, ESE can also play an important role in weight maintenance. Foreyt et al. [22] found that weight maintainers had better ESE related to negative affect than individuals who regained weight. Similarly, Pedersen et al. [57] found that long-term maintainers reported a wider range of self-regulatory strategies than short-term maintainers, which also involved self-efficacy related to meal planning and shopping. It is interesting to note, however, that Clark and King [58] found no change in ESE levels in case of weight cycling. Beyond individual characteristics, some studies have identified that parental self-efficacy can influence children’s food choices and their adoption of weight-protective behaviours [33, 59–61].

Positive correlations have been observed between ESE and well-being, affective balance [62], self-esteem [63] and obesity-specific quality of life after sleeve gastrectomy [50]. Conversely, some authors have reported negative correlations between ESE and symptoms of eating disorders [64-66], stress [55, 67] and depression [68, 69]. Annesi [70] even identified ESE as a mediator between depression and emotional eating.

In contrast, the links between ESE and sociodemographic variables produced inconsistent results. While some studies reported higher ESE levels in women, [18], others showed opposite results suggesting that men have higher ESE levels [22, 48, 65, 71]. However, according to Presnell, Pells, Stout and Musante [52], these gender differences disappeared after treatment. Some studies have not identified significant differences in ESE levels according to participants’ gender [58, 68]. Furthermore, various studies have reported negative correlations between ESE and BMI [18, 40, 47, 51, 63, 65, 72, 73]. Only one study found that patients with increased BMI had higher ESE scores [68] and a few reported insignificant correlations between BMI and ESE [48, 52, 64]. According to Ames et al. [68], younger participants had higher ESE levels but no significant correlation between these two variables was found in other studies [47, 64]. Nevertheless, results involving sociodemographic variables should be considered with caution since, in a vast majority of studies, participants were predominantly women (61%– 91% female sample, sometimes even only female), overweight and/or suffering from obesity and, mostly enrolled in a weight-loss treatment. Furthermore, the majority of studies were conducted on American adults, while only few studies included European samples (Spain [62], Norway [74], Germany [41], Denmark [57] and Italy [65]). Moreover, caution should be exercised since the data in these studies were collected using different ESE questionnaires.

The first eating self-efficacy Scale was created in 1984 by Jeffery et al. [75]. The scale consists of 30 items: 15 items evaluating feeling self-efficacy (the person’s ability to resist eating when feeling certain emotions) and 15 items regarding situational self-efficacy (resisting the urge to eat when engaging in certain activities). The development of eating-self efficacy scales has been widely expanded with more than dozens of different ESE scales available, some of them being addressed to specific populations such as low-income women [55, 76], students [77], children and their parents [33] or athletes [66]. Some scales have been developed recently to assess ESE in relation to specific diets such as Mediterranean Diet [62] or gluten-free diet for people suffering from celiac disease [71]. The Weight Efficacy Life-Style questionnaire (WEL) developed by Clark, Abrams, Niaura, Eaton and Rossi [39] is one of the most widely used. It has been used in many studies [18, 42, 51, 53, 54, 56, 68–70, 78–80] and populations such as adults suffering from cancer [51], type 2 diabetes [81] or adults with obesity and enrolled in different weight loss programs [39, 42, 53, 54, 58, 69, 70, 78], as well as candidates for bariatric surgery [50, 68, 78], and adults of normal weight following a calorie restriction program [40]. The WEL was validated in Malay in a study by Singh et al. [81]. A short form has been created in English (WEL-SF [78]) which was later validated in Norwegian [74]. Apart from the Self-Regulation of Eating Attitude in Sports Scale of Scoffier et al. [66], there are currently no ESE scales in French, no French validation of the WEL, and no studies having explored the role of ESE among French speaking individuals with obesity. Furthermore, although some associations between self-efficacy and self-esteem, depression, well-being and stress have already been noted, additional research is needed to confirm and further explore these links. Thus, the present study was conducted to explore the relationship between eating self-efficacy and psychosocial correlates related to normal weight and obesity in French adults. Therefore, its aim was twofold. The first objective was to validate the French version of the scale and to explore its reliability, sensibility and measurement invariance in the general adult population and a clinical sample of overweight adults and those living with obesity. The second objective was to explore the links between eating self-efficacy, sociodemographic variables, self-esteem, perceived stress, depression and well-being among these two samples.

2. Study 1

The aim of this study was to validate the French version of the WEL in the general adult population, explore its factorial structure, reliability and sensibility as well as the links with other psychosocial and sociodemographic variables.

2.1. Methods

2.1.1. ESTEAM cohort

ESTEAM is the acronym of “Etude Scientifique des Tendances Empêchant un Amaigrissement Maintenu” in French (translated in English as “Scientific Assessment of Tendencies Preventing Maintained Weight Loss”). It is a web-based retrospective study, funded by PiLeJe Laboratoire, a French pharmaceutical laboratory. Recruitment of the study population started in January 2014 and is still ongoing. This dynamic cohort contains data from psychological variables (such as depression, well-being, eating self-efficacy, perceived stress or self-esteem), collected from participants whose motivations to consult concern achieving and maintaining a healthy weight. Participants are recruited during a consultation with their doctor and on a voluntary basis. If the participant accepts to take part in the study, the doctor then creates his or her account. Participants can fill out the forms after each consultation with their practitioner, creating a follow-up database. Questionnaires can be completed directly online. Data storage is carried out by an independent host, certified by the French Ministry of Health and approved by French legislation. Each general practitioner is agreed by CNIL. Comité National Informatique et Liberté (National Comission on Informatics and Liberty in English) with a specific registration number.

When a new patient account is created, the physician asks for the patient’s informed oral consent and checks the corresponding box on the software. The informed consent of the patient or their legal representative (parental authority for a minor, legal guardian for an adult under supervision) is mandatory for the creation of the patient account and the hosting of the collected data. The patient consent is dematerialized (stored in the computer system and not in the form of a paper document) and traced (the date of consent and the identity of the person who collects it are also kept). The extracted data are pseudoanonymized. Pseudonymisation is the processing of personal data carried out in such a way that data relating to an individual can no longer be attributed without additional information. Pseudonymization is one of the measures recommended by the General Data Protection Regulation (GDPR) to limit the risks associated with the processing of personal data (https://www.cnil.fr/fr/lanonymisation-de-donnees-personnelles): they contain the patient number.

2.1.2. Participants

The designated sample for the WEL validation analysis consisted of 432 participants (93% of whom were female). After removing participants whose gender or BMI data were missing in other scales, 374 participants (78% of whom were female) were included in the final sample intended for mean comparison and correlational analyses. For ethical reasons, participants were excluded if their age was under 18. Additionally, due to a low rate of participants over the age of 64, we decided to include those whose ages ranged from 18 to 64 (mean age 43.18 years, SD = 11.93). Moreover, participants were included if their BMI was less than 25 kg / m2 (average BMI = 22.36 kg/m2, SD = 2.16) and if they had completed the questionnaire only once in 21 days. Two hundred and one participants from the final sample filled out the depression questionnaire in addition to other scales.

2.1.3. Measures

2.1.3.1. Eating self-efficacy. Eating self-efficacy was assessed using the French version of the Clark, Abrams, Niaura, Eaton and Rossi’s Weight Efficacy Life-Style Questionnaire (WEL, 1991). The original items of the scale were adapted from Condiotte and Lichtenstein’s Smoking Confidence Questionnaire (1981) [31] and some additional items were created from results of a clinical experience and the administration of the scale to a sample of patients with obesity. The original version of the WEL consists of 20 items, scored on a Likert-type scale (0: Not confident, 9: Very confident) and assembled into five different factors evaluating the individual’s confidence of “being able to resist their desire to eat” [39] in the following situations: Negative emotions (items 1, 6, 11, 16), Availability (items 2, 7, 12, 17), Social Pressure (items 3, 8, 13, 18), Physical Discomfort (items 4, 9, 14, 19) and Positive Activities (items 5, 10, 15, 20). An important level of eating self-efficacy is characterized by a high score on the WEL. The values of Cronbach’s alpha coefficient of all the scales used in this study are presented in Table 1.

Table 1

Cronbach’s alpha coefficient of the scales used in studies 1 and 2.

	General sample	Clinical sample
	(study 1)	(study 2)
Variables	α	α
WEL	0.91	0.91
External stimuli	0.91	0.88
Internal stimuli	0.90	0.90
SSES	0.84	0.85
Performance	0.81	0.83
Social	0.80	0.81
Appearance	0.85	0.84
WHO-5	0.89	0.88
MDI	0.82	0.84
PSS-11	0.87	0.87

Note. WEL = Weight Efficacy Life-Style Questionnaire; SSES = State Self-Esteem Scale; WHO-5 = World Health Organisation Well-Being index; MDI = Major Depression Inventory; PSS-11 = Perceived Stress Scale.

2.1.3.2. Well-being. Well-being was evaluated with the WHO-5 Well Being Index, created and validated in French by the Psychiatric Research Unit WHO Collaborating Centre in Mental Health [82]. It is a unidimensional, 5-item questionnaire, evaluated using a Likert-type scale (0: at no time, 5: all of the time). A higher score on the scale indicates a higher level of well-being.

2.1.3.3. Depressive symptomatology. Depressive symptomatology was appraised using a French adaptation of the Major Depression Inventory (MDI), created by Psychiatric Research Unit [83] and specifically translated for the purpose of this study, following the usual scientific translation procedures [84]. It is a unidimensional scale consisting of 10 Likert-type items (0: At no time, 5: All of the time). This scale was administered only to participants who responded “At no time” or “Some of the time” on one of the five items of the WHO-5 scale or whose total WHO-5 score was inferior to 50. A high score on the MDI scale indicates a significant level of depressive symptomatology.

2.1.3.4. State self-esteem. State self-esteem was measured using the State Self-Esteem Scale (SSES) [85]. The original version of the SSES includes 20 items, scored on a Likert-type scale (1: Not at all; 5: Extremely) and grouped in three dimensions in order to assess performance self-esteem, social self-esteem and appearance self-esteem. In this research, a French version of the scale containing 12 items organized also in three dimensions was translated for the purpose of this study. A high score on this scale is a sign of high state self-esteem.

2.1.3.5. Perceived stress. Perceived stress was assessed with the Cohen, Kamarck and Mermelstein’s Perceived Stress Scale (PSS) [86]. This unidimensional scale embodies 14 Likert-type items (1: Never, 5: Very often). A French version embodying 11 items was used in this study. A state of high stress is characterized by a high score on the scale.

2.1.3.6. Anthropometric and demographic information. In addition to the aforementioned questionnaires, the medical practitioner reported the participant’s age, gender, weight and height, the latter two allowing their Body Mass Index (BMI) to be calculated.

2.1.4. Statistical analysis

In order to investigate the factorial structure of the WEL questionnaire, an exploratory factor analysis (EFA) followed by a confirmatory factor analysis (CFA) were performed. The data set was randomly split in half in order to carry out independent EFA and CFA analyses. Prior to the analysis, multivariate and univariate normalities of data were explored using the Mardia’s coefficient and Shapiro-Wilk test, respectively. It was considered that data do not follow the normal distribution when the Mardia’s coefficient |z| score exceeds 5 and the Shapiro-Wilk test is significant (p < 0.05) [87] (p.32).

In addition, CFA was carried out on other scales used in the present study. These analyses confirmed the original structure of the WHO-5 and MDI while suggesting reduced versions of the SSES and the PSS in terms of number of retained items: the French version of the SSES scale contained 12 items instead of 20, and the French version of the PSS scale contained 11 instead of 14 items. However, the number of factors remained the same.

2.1.4.1. Exploratory factor analysis (EFA). The EFA was carried out on a first randomly split sample. Inter-item correlations as well as the Kaiser-Meyer-Olkin index (KMO) and the Bartlett sphericity index were calculated beforehand to determine if the data were suitable for an EFA. The significant values of the correlation coefficients and the Bartlett index (p < 0.05) as well as the satisfactory value of the KMO coefficient (KMO ≥ 0.70) indicated that the factor analysis could be performed as follows. The factor extraction method was chosen based on the normality of the distribution [87] (p.26). The number of factors retained was established using parallel analysis (eigenvalue > 1) and the Cattell criterion [88]. Finally, items that were not significantly correlated with other items of the scale, whose factor loadings were too low (< 0.40) or were loading on two or more factors were dismissed from the model.

2.1.4.2. Confirmatory factor analysis (CFA). Subsequently, CFA was conducted on the other split-half sample, testing the model derived from the EFA and using the lavaan package [89]. The goodness of fit of the model was analysed using the following indexes: χ2 / df, Comparative Fit Index (CFI), Tucker-Lewis Index (TLI), Adjusted Goodness-of-Fit Index (AGFI), Root Mean Square Error of Approximation (RMSEA) and Standardized Root Mean Square (SRMR). Acceptable fit was considered when χ2 / df was inferior to 5, when CFI, TLI and AGFI values were superior to 0.90 and when RMSEA and SRMR values were less than 0.8 with values inferior to 0.6 being considered as excellent [90].

2.1.4.3. Reliability and sensibility of the WEL. The reliability of the WEL was studied by considering its internal consistency and using the split-half method. The internal consistency of the French version of the scale and its dimensions were analysed by calculating the Cronbach coefficient alpha (α). The interpretation of its value was based on the following criteria: α < 0.60—unacceptable; 0.60 > α > 0.70—correct; 0.70 > α > 0.80—satisfactory; 0.80 > α > 0.90—very good; α > 0.95—problematic [91]. Furthermore, the reliability of the scale was considered satisfactory if the interclass correlation coefficient (ICC), measured between even and odd items, was greater than 0.70 [92, 93]. Sensibility was investigated by performing discrimination analysis of items and by calculating the Ferguson’s δ coefficient. This analysis relied on the following criteria: items with d < 0.20 are poor and need to be revised or eliminated; items with d of 0.20–0.29 are marginal and need revision; items with d of 0.30–0.39 are reasonably good but can be improved and items with d > 0.40 are very good [94]. Ferguson’s δ coefficient expresses the extent to which the scale discriminates between individuals and ranges from 0 to 1. A delta close to 0 indicates that all subjects have the same score while a delta close to 1 indicates that each subject has a different score [95].

2.1.4.4. Relationships with sociodemographic and psychological variables. The links between different variables were explored using nonparametric Spearman’s rhô correlation coefficients. Non-parametric Kruskal-Wallis and Wilcoxon–Mann–Whitney U tests were conducted in order to identify any significant differences based on participants’ gender, age and BMI. Cohen’s d coefficient and η2 index were applied in order to evaluate the size effect of those differences. According to Cohen [96], a size effect equal to 0.20 is considered small, a Cohen’s d equal to 0.50 is considered as a medium effect and d = 0.80 is regarded as a large size effect. All the statistical analyses were performed using the R version 3.4.2. for Windows.

2.2. Results

Mean scores and standard deviations of the assessment scales used in the general French population sample are presented in Table 2.

Table 2

Means and standard deviations of the measured variables in a sample of the general French population.

Variables	M (SD)	Minimal	Maximal
WELa	71.17 (22.24)	5	108
External stimuli a	30.79 (10.25)	1	45
Internal stimuli a	40.37 (15.26)	0	63
SSES a	46.45 (10.29)	19	73
Performance a	25.21 (5.46)	9	35
Social a	10.89 (3.74)	4	20
Appearance a	10.35 (4.35)	4	20
WHO-5 a	52.22 (22.75)	0	100
MDI b	22.93 (8.48)	5	50
PSS-11a	31.39 (7.77)	12	51
Age a	43.18 (11.93)	18	64
BMI a	22.36 (2.16)	13.3	24.99

Note.

= Total sample (N = 374)

= participants that responded to the MDI scale (n = 201); WEL = Weight Efficacy Life-Style Questionnaire; SSES = State Self-Esteem Scale; WHO-5 = World Health Organisation Well-Being index; MDI = Major Depression Inventory; PSS-11 = Perceived Stress Scale; BMI = Body Mass Index.

2.2.1. Exploratory Factor Analysis (EFA)

EFA was carried out on a first randomly split sample (n = 224). The absolute value of Mardia’s coefficient | z | score was greater than 5 (| z | = 71.89, p = 0.00) and the Shapiro-Wilk test was significant (p < 0.001), indicating a defect in the multivariate and univariate normalities of the data. Therefore, nonparametric statistics were applied for the analyses performed on the French version of the WEL. The Bartlett’s sphericity test and KMO were satisfactory (Bartlett test: χ (190) = 2972.932, p < 0.001; KMO = 0.94), confirming the suitability of the data for the EFA. The factor extraction method applied was the principal axis method since it does not require a normal distribution of the data [87] along with a varimax rotation, which was applied in the study by Clark et al. [39]. Analysis of the correlation matrix indicated that all items were significantly correlated with each other. Examination of the Cattell index and parallel analysis suggested a 2-factor solution. Items 2, 5, 7, 9, 10, 15, 17 and 20 were saturating on both factors and were hence excluded from the final model. The remaining 12 items explained 55% of the total variance. The EFA results are presented in Table 3.

Table 3

Exploratory factor analysis results of the French version of the weight efficacy Life-Style questionnaire, carried out on the general population sample (n = 224).

	Factor loadings
WEL items	F1	F2
1. I can resist eating when I am anxious (nervous).	0.8	0.24
2. I can control my eating on the weekends.	0.56	0.4
3. I can resist eating even when I have to say ‘‘no” to others.	0.29	0.79
4. I can resist eating when I feel physically run down.	0.65	0.23
5. I can resist eating when I am watching TV.	0.56	0.33
6. I can resist eating when I am depressed (or down).	0.81	0.16
7. I can resist eating when there are many different kinds of foods available.	0.44	0.62
8. I can resist eating even when I feel it’s impolite to refuse a second helping.	0.2	0.84
9. I can resist eating even when I have a headache.	0.5	0.28
10. I can resist eating when I am reading.	0.47	0.26
11. I can resist eating when I am angry (or irritable).	0.75	0.2
12. I can resist eating even when I am at a party.	0.32	0.64
13. I can resist eating even when others are pressuring me to eat.	0.17	0.83
14. I can resist eating when I am in pain.	0.65	0.22
15. I can resist eating just before going to bed.	0.49	0.32
16. I can resist eating when I have experienced failure.	0.84	0.19
17. I can resist eating even when high-calorie foods are available.	0.51	0.57
18. I can resist eating even when I think others will be upset if I don’t eat.	0.18	0.78
19. I can resist eating when I feel uncomfortable.	0.73	0.16
20. I can resist eating when I am happy.	0.51	0.29

Note. Items in italics have been withdrawn from the French version used in study 1.

2.2.2. Confirmatory Factor Analysis (CFA)

CFA was carried out on the second randomly split sample (n = 208) using the MLR estimator. The first tested model was the 2-factor, 12-item solution. The results were the following: χ2/df = 2.55; RSMEA = 0.086; SRMR = 0.072; AGFI = 0.848; CFI = 0.948; TLI = 0.935. Given the inadequate AGFI and RMSEA values, a second model was tested, incorporating the suggested modification indices. Hence, five correlated errors were added between items 3 and 18, items 11 and 19, items 1 and 6, items 1 and 3 and, lastly, items 12 and 18. These modifications significantly improved the overall fit of the model, according to the following Goodness of Fit Indices: χ2/df = 1.67; RSMEA = 0.057; SRMR = 0.060; AGFI = 0.901; TLI = 0.972; CFI = 0.980. CFA results are displayed in Table 8. Considering the content of each subscale, the terms “External stimuli” (composed of items 3, 8, 12, 13 and 18) and “Internal stimuli” (items 1, 4, 6, 11, 14, 16 and 19) were given.

Table 8

Goodness of fit indices of the two weight efficacy Life-Style questionnaire versions used in study 1 and study 2.

Study	χ 2	p	χ 2/df	RMSEA	SRMR	AGFI	TLI	CFI
Study 1	80.2	0.00	1.67	0.057	0.06	0.901	0.972	0.980
Study 2	227.963	0.00	5.56	0.066	0.040	0.938	0.964	0.973

Note. RMSEA = Root Mean Square Approximation; SRMR = Standardized Root Mean Square; AGFI = Adjusted Goodness-of -Fit Index; TLI = Tucker-Lewis Index; CFI = Comparative Fit Index.

Due to the low proportion of underweight individuals and men in the general population sample, we were unable to perform multigroup confirmatory factor analysis to assess cross-BMI and cross-gender measurement invariance in this sample.

2.2.3. Reliability and sensibility of the WEL

The intra-class coefficient (ICC) with a Spearman-Brown correction was calculated between even and odd items and was equal to 0.92. Cronbach’s alpha coefficient was 0.91 for the “External stimuli” dimension, 0.90 for the “Internal stimuli” dimension and 0.91 for the whole scale. Ferguson’s δ coefficient was equal to 0.99 and discrimination analysis of the items was satisfactory, the discrimination index being superior to 0.40 for all items. These combined results support the hypothesis of adequate reliability and sensibility of the French version of the WEL.

2.2.4. Relationships with sociodemographic and psychological variables

Analysis of the univariate and multivariate normalities indicated that the data from the SSES, PSS-11, WHO-5 and MDI questionnaires and their subscales were not distributed normally (Mardia’s coefficient: | z | > 5, Shapiro normality test: p < 0.001). Therefore, the study of the links between the variables was carried out using nonparametric Spearman rhô correlation coefficients. Correlation coefficient values are presented in Table 4.

Table 4

Correlations between measured variables: Results from study 1.

	1.	2.	3.	4.	5.	6.	7.	8.	9.	10.	11.
1. Agea	-
2. BMIa	0.19***	-
3. WELa	0.05	-0.19***	-
4.WEL-ISa	-0.01	-0.15**	0.81***	-
5. WEL-ESa	0.07	-0.17**	0.92***	0.50***	-
6. SSESa	0.12*	-0.07	0.51***	0.42***	0.46***	-
7. SSES-Sa	0.14**	0	0.28***	0.27***	0.22***	0.63***	-
8. SSES-Pa	-0.01	0.01	0.40***	0.33***	0.36***	0.84***	0.31***	-
9. SSES-Aa	0.18***	-0.17***	0.48***	0.35***	0.46***	0.76***	0.25***	0.47***	-
10. PSS-11a	-0.08	0.02	-0.41***	-0.29***	-0.40***	-0.60***	-0.29***	-0.53***	-0.50***	-
11.WHO-5a	0.01	-0.07	0.42***	0.30***	0.41***	0.57***	0.21***	0.51***	0.51***	-0.64***	-
12. MDIb	0.16*	0.06	-0.28***	-0.15*	-0.30***	-0.50***	-0.23***	-0.51***	-0.31***	0.56***	-0.62***

Note.

= Total sample (N = 374)

= participants who responded to the MDI (n = 201); BMI = Body Mass Index; WEL = Weight Efficacy Life-Style Questionnaire; WEL–IS = Internal Stimuli; WEL–ES = External Stimuli; SSES = State Self-Esteem Scale; SSES–S = State Self-Esteem–Social scale; SSES–P = State Self-Esteem–Performance scale; SSES–A = State Self-Esteem–Appearance scale; PSS-11 = Perceived Stress Scale; WHO-5 = World Health Organization Well-Being index; MDI = Major Depression Inventory.

* p<0.05

** p<0.01

*** p<0.001.

BMI displayed negative correlations with the total WEL score (rhô = -0.19) and its two subscales “Internal stimuli” (rhô = -0.15) and “External stimuli” (rhô = -0.17). The total WEL score and its two subscales were strongly correlated with each other. They also displayed identical correlation pattern with other variables. The total WEL score and the two subscales “Internal stimuli” and “External stimuli” were positively correlated with the total SSES score (rhô = 0.51; rhô = 0.42 and rhô = 0.46, respectively) and its subscales “Social (rhô = 0.28; rhô = 0.27 and rhô = 0.22, respectively), “Performance” (rhô = 0.40; rhô = 0.33 and rhô = 0.36, respectively) and “Appearance” (rhô = 0.48, rhô = 0.35 and rhô = 0.46, respectively). Additionally, they were positively correlated with the WHO-5 (rhô = 0.42; rhô = 0.30 and rhô = 0.41, respectively). On the other hand, negative correlations were observed between the total WEL score, “Internal stimuli”, “External stimuli” subscales and PSS-11 (rhô = -0.41, rhô = -0.29 and rhô = -0.40, respectively) and MDI score (rhô = -0.28; rhô = -0.15 and rhô = -0.30, respectively).

Since data were not normally distributed, non-parametric Wilcoxon–Mann–Whitney U tests were used for mean comparison analyses. Significant differences in WEL scores and its two subscales were observed between the two BMI categories. Participants in the “Underweight” category had higher scores than those in the “Normal weight” category (p < 0.05). The size effect of those differences was respectively, d = -0.49, d = -0.45, and d = 0.14. Similarly, age seemed to be significantly different in the two BMI categories with participants in the “Underweight” category being younger than those in the “Normal weight” category (p < 0.001, d = 0.79). Results are displayed in Table 5. However, since 25 participants were included in the “Underweight” category, these results need to be confirmed in a larger sample.

Table 5

Means, standard deviations and Wilcoxon–Mann–Whitney statistics for study 1 variables.

	Female	Male		Underweight	Normal weight
				(n = 25)
					(n = 349)
	(n = 291)	(n = 83)
Measure	M (SD)	M (SD)	U (1, 372)	M (SD)	M (SD)	U (1,372)	d
BMIa	22.40 (2.04)	22.19 (2.55)	12076	17.10 (1.31)	22.73 (1.67)	8725***	3.42
Agea	43.19 (11.76)	43.17 (12.60)	5965	34.52 (14.13)	43.80 (11.53)	60695***	0.79
WELa	69.56 (22.47)	84.37 (18.15)	11194	81.44 (25.32)	70.43 (21.86)	2989**	-0.49
WEL-ISa	40.1 (15)	41.34 (16.18)	11397	46.76 (16.22)	39.92 (15.11)	3109.5*	-0.45
WEL-ESa	30.42 (10.37)	32.12 (9.8)	10897	34.68 (11.40)	30.52 (10.13)	3076*	0.14
SSESa	46.6 (10.25)	45.92 (10.45)	12639	49.04 (10.01)	46.27 (10.29)	3732.5
SSES-Sa	10.96 (3.73)	10.65 (3.79)	12664	11.04 (3.81)	10.88 (3.74)	4334
SSES-Pa	25.21 (5.55)	25.23 (5.15)	12174	26.16 (5.33)	25.14 (5.47)	3847
SSES-Aa	10.44 (4.35)	10.04 (4.38)	1271	11.84 (4.09)	10.24 (4.36)	3400.
PSS-11a	31.29 (7.78)	31.73 (7.74)	11800	32.72 (7.47)	31.30 (7.77)	3881
WHO-5a	51.77 (23.12)	53.82 (21.43)	11528	54.56 (18.54)	52.06 (23.03)	4132
	Female	Male		Underweight	Normal weight
				(n = 11)
					(n = 190)
	(n = 159)	(n = 42)
Variable	M (SD)	M (SD)	U (1,199)	M (SD)	M (SD)	U (1,199)
MDIb	23.06 (8.59)	22.43 (8.14)	23347	23.91 (5.11)	22.87 (8.64)	946

Note.

= Total sample (n = 374)

= participants that responded to the MDI scale (n = 201); WEL = Weight Efficacy Life-Style Questionnaire; WEL–IS = Internal Stimuli; WEL–ES = External Stimuli; SSES = State Self-Esteem Scale; SSES–S = State Self-Esteem–Social scale; SSES–P = State Self-Esteem–Performance scale; SSES–A = State Self-Esteem–Appearance scale; PSS-11 = Perceived Stress Scale; WHO-5 = World Health organization Well-Being index; MDI = Major Depression Inventory; BMI = Body Mass Index.. p<0.1

* p<0.05

** p<0.01

*** p<0.001.

2.3. Discussion

Results from EFA and CFA showed that the French 12-item-version of the WEL (WEL-Fr-G) is a psychometrically sound tool for assessing eating self-efficacy in a general population.

3. Study 2

The aim of study 2 was to validate the French version of the WEL in a clinical sample of French adults who were overweight or suffering from obesity as well as explore its psychometric properties (its factorial structure, reliability and sensibility) and its measurement invariance. This study also aimed to explore the links between eating self-efficacy and other psychological and sociodemographic variables.

3.1. Methods

3.1.1. Participants

Inclusion criteria for age were the same as in study 1 but inclusion criteria for BMI were different: participants with a BMI ≥ 25 kg/m2 were included. In total, 2010 adults (87% of whom were women) completed the French version of the WEL. Their responses were used for the validation analysis of the scale. After removing participants whose gender or BMI data were missing from the other scales, 1737 participants (82% of whom were women) were included in the final sample for mean comparison and correlational analyses. Mean age was 44.44 years (SD = 11.25) and mean BMI was 32.29 kg/m2 (SD = 5.62). A total of 967 participants in this sample completed the MDI questionnaire in addition to other scales.

3.1.2. Procedure

The same scales and statistical analyses as used in study 1 were applied in study 2 as well as an additional analysis of the measurement invariance of the WEL. To assess the measurement invariance of the scale across different BMI and gender categories, a series of multigroup confirmatory factor analyses (MGCFA) were performed using the lavaan [89] and semTools [97]. The measurement invariance was first tested across four different BMI categories: overweight group (BMI between 25.00 and 29.99 kg/m2), category I obesity (BMI between 30.00 and 34.99 kg/m2), category II obesity (BMI between 35.00 and 39.99 kg/m2) and category III obesity (BMI above 40.00 kg/m2). The measurement invariance was then tested between women and men. Four different models were tested and compared with each other. Model 1 tested configural invariance (testing of the hypothesized model across the different weight or gender categories, without constraints). Model 2 tested metric invariance (factor loadings were constrained to equality across weight or gender categories). Model 3 tested scalar invariance (factor loadings and item intercepts were constrained to equality between categories). Finally, model 4 tested strict invariance (factor loadings, item intercepts and item error variance were constrained to equality between categories). Measurement invariance of the models was supported if Δχ was not significant, ΔCFI ≤ 0.005, ΔRMSEA ≤ 0.01 and ΔSRMR ≤ 0.025 for the metric invariance test and if ΔCFI ≤ 0.005, ΔRMSEA ≤ 0.01 and ΔSRMR ≤ 0.005 for the scalar and strict invariance tests [98]. Before comparing the models, it was ensured that the configural model had an acceptable fit. For this purpose, the aforementioned CFA criteria were applied. After inspection of the configural model, measurement invariance was explored by comparing the four models with each other.

3.2. Results

Mean scores and standard deviations of the tools used in the second study are displayed in Table 6.

Table 6

Means and standard deviations of the assessment scales used in a French clinical sample.

Variables	M (SD)	Minimal	Maximal
WEL a	58.64 (20.55)	0	99
Internal stimuli a	24.37 (12.01)	0	45
External stimuli a	34.27 (11.51)	0	54
SSES a	44.12 (9.53)	15	73
Performance a	25.13 (5.30)	7	35
Social a	10.97 (3.77)	4	20
Appearance a	8.02 (3.93)	4	20
WHO-5 a	51.45 (22.96)	0	100
MDIb	23.4 (8.77)	2	49
PSS-11 a	31.54 (7.87)	11	55
Age a	44.44 (11.25)	18	64
BMI a	32.29 (5.62)	30	67.5

Note.

= Total sample (N = 1737)

= participants that responded to the MDI scale (n = 967); WEL = Weight Efficacy Life-Style Questionnaire; SSES = State Self-Esteem Scale; WHO-5 = World Health Organisation Well-Being index; MDI = Major Depression Inventory; PSS-11 = Perceived Stress Scale; BMI = Body Mass Index.

3.2.1. Exploratory Factor Analysis (EFA)

EFA was carried out on a first randomly split sample. Forty-seven values were identified as outliers of the item 10 and were therefore excluded from the analysis. The final sample intended for the EFA included 924 participants. The absolute value of the Mardia’s coefficient z score was greater than 5 (| z | = 123.441, p = 0.00) and the Shapiro-Wilk test was significant (p <0.001), hence nonparametric statistics were applied. The Bartlett’s sphericity test and the Kaiser-Meyer-Olkin index (KMO) were satisfactory (Bartlett test: χ2 (190) = 10132.75, p < 0.001; KMO = 0.94), indicating that data were suitable for EFA. Principal axis method was also used in this study as a factor extraction method. The correlation matrix indicated that all items were significantly correlated with each other. As in study 1, examination of the Cattell index and parallel analysis suggested a 2-factor solution. Items 2, 4, 5, 9, 10, 14, 15, 17 and 20 were saturating on both factors and were hence excluded from the factorial solution. The remaining 11 items accounted for 48% of the variance. The EFA results are presented in Table 7.

Table 7

Exploratory factor analysis results of the French version of the weight efficacy Life-Style questionnaire, carried out on the clinical sample (n = 924).

	Factor loading
WEL items	F1	F2
1. I can resist eating when I am anxious (nervous).	0.29	0.77
2. I can control my eating on the weekends.	0.58	0.38
3. I can resist eating even when I have to say ‘‘no” to others.	0.76	0.28
4. I can resist eating when I feel physically run down.	0.32	0.53
5. I can resist eating when I am watching TV.	0.35	0.33
6. I can resist eating when I am depressed (or down).	0.21	0.83
7. I can resist eating when there are many different kinds of foods available.	0.63	0.30
8. I can resist eating even when I feel it’s impolite to refuse a second helping.	0.75	0.14
9. I can resist eating even when I have a headache.	0.43	0.33
10. I can resist eating when I am reading.	0.41	0.24
11. I can resist eating when I am angry (or irritable).	0.23	0.70
12. I can resist eating even when I am at a party.	0.58	0.20
13. I can resist eating even when others are pressuring me to eat.	0.78	0.18
14. I can resist eating when I am in pain.	0.37	0.42
15. I can resist eating just before going to bed.	0.35	0.32
16. I can resist eating when I have experienced failure.	0.25	0.80
17. I can resist eating even when high-calorie foods are available.	0.64	0.36
18. I can resist eating even when I think others will be upset if I don’t eat.	0.73	0.21
19. I can resist eating when I feel uncomfortable.	0.24	0.71
20. I can resist eating when I am happy.	0.48	0.22

Note. Items in italics have been withdrawn from the version used in study 2.

3.2.2. Confirmatory Factor Analysis (CFA)

CFA was carried out on the second randomly split sample (n = 1039) using MLR estimator. The first tested model was the 2-factor solution with 11 items. The results were: χ2/df = 9.84; RSMEA = 0.091; SRMR = 0.046; AGFI = 0.895; CFI = 0.947; and TLI = 0.932. Given the inadequate values of some indexes (i.e. χ2/df, AGFI and RMSEA) a second model was tested, incorporating the suggested modification indices. Hence, two correlated errors between items 7 and 12 and items 3 and 18 were added, significantly improving the overall fit of the model. The results from this second and final analysis were: χ2/df = 5.56; RSMEA = 0.066; SRMR = 0.040; AGFI = 0.938; TLI = 0.964; CFI = 0.973. CFA results are presented in Table 8. Given the content of each subscale, names identical to those in study 1 were given to the subscales: “External stimuli” (composed of items 3, 7, 8, 12, 13, and 18) and “Internal stimuli” (including items 1, 6, 11, 16 and 19).

3.2.3. Multigroup confirmatory factor analysis (MGCFA)

A series of MGCFA was conducted to test for cross-BMI and cross-gender measurement invariance.

3.2.3.1. Measurement invariance across BMI categories. For this analysis, the 2010 participants were divided into four categories according to their BMI. The overweight category included 841 participants (91% female; mean age = 45.18, SD = 11.32, age range: 18–64 years; mean BMI = 27.49 kg/m2, SD = 1.43). Category I obesity was composed of 661 participants (84% female; mean age = 44.38, SD = 11.42, age range: 18–64 years; mean BMI = 32.23 kg/m2, SD = 1.47). Category II obesity included 306 participants (85% female; mean age = 43.78, SD = 11.34, age range: 18–64; mean BMI = 37.2 kg/m2, SD = 1.63) and category III obesity had 202 participants (85% female; mean age = 44.1, SD = 10.86, age range: 19–64 years; mean BMI = 44.14 kg/m2, SD = 4.13).

First, a regular CFA was carried out separately in each of the four BMI categories.

The fit indices of the model tested in the four groups were good, as presented in Table 9.

Table 9

Goodness of fit indices of models testing for Cross-BMI and Cross-gender invariance in study 2.

	CFI	SRMR	RMSEA	χ 2	ΔCFI	ΔSRMR	ΔRMSEA	Δ χ 2
BMI category
Overweight	0.974	0.043	0.065	146.183
Category I obesity	0.982	0.043	0.056	105.143
Category II obesity	0.987	0.041	0.048	61.687
Category III obesity	0.984	0.051	0.049	54.980
Gender group
Female	0.977	0.040	0.061	235.085
Male	0.987	0.039	0.047	58.644
Cross-BMI invariance
Configural	0.980	0.044	0.058	365.663
Metric	0.979	0.049	0.055	412.994	0.001	0.005	0.003	47.33*
Scalar	0.978	0.050	0.052	451.663	0.001	0.001	0.003	38.67
Strict	0.977	0.049	0.050	490.183	0.001	0.001	0.002	38.52
Cross-gender invariance
Configural	0.978	0.040	0.060	296.083
Metric	0.978	0.042	0.057	312.749	0.000	0.002	0.003	16.67
Scalar	0.976	0.043	0.056	342.899	0.002	0.001	0.001	30.15***
Strict	0.976	0.044	0.053	349.69	0.000	0.001	0.003	6.79

Note. CFI = Comparative Fit Index; RMSEA = Root Mean Square Approximation; SRMR = Standardized Root Mean Square.

* p<0.05

** p<0.01

***p<0.001.

Overweight: CFI = 0.974; TLI = 0.965; SRMR = 0.043; RMSEA = 0.065 (90% CI 0.053–0.076);

Category I: CFI = 0.982; TLI = 0.975; SRMR = 0.043; RMSEA = 0.056 (90% CI 0.043–0.069);

Category II: CFI = 0.987; TLI = 0.983; SRMR = 0.041; RMSEA = 0.048 (90% CI 0.020–0.071);

Category III: CFI = 0.984; TLI = 0.979; SRMR = 0.051; RMSEA = 0.049 (90% CI 0.020–0.080).

Subsequently, four different models were explored, testing respectively for configural, metric, scalar and strict factorial invariance. Comparison of the configural and metric measurement invariance showed that the added constraint of factor loadings did not significantly weaken the goodness of fit (ΔCFI = 0.001; ΔSRMR = 0.005; ΔRMSEA = 0.003; Δχ = 47.33, p = 0.03). Then, comparison of model 3 and model 2 revealed that the additional constraints requiring items’ intercept equality did not significantly worsen the fit (ΔCFI = 0.001; ΔSRMR = 0.001; ΔRMSEA = 0.003; Δχ = 38.67). Lastly, comparison of model 4 and model 3 pointed out that the further constraint expecting item error variances to be equal did not significantly affect the fit (ΔCFI = 0.001; ΔSRMR = 0.001; ΔRMSEA = 0.002; Δχ = 38.52). These results support the idea of WEL invariance according to the BMI.

3.2.3.2. Measurement invariance across gender. A MGCFA analysis was run to examine the measurement invariance of the French version of the WEL across gender. For this analysis, the 2010 participants were divided according to their gender, i.e. into a group of 1747 women (mean age = 44.37, SD = 11.31, age range: 18–64 years) and a group of 263 men (mean age = 46.08, SD = 11.25, age range: 18–64 years). Just like in the previous analysis, a regular CFA was conducted separately in each of the two groups.

The fit indices of the model tested across the two gender groups were satisfactory: in the group of women: CFI = 0.977; TLI = 0.969; SRMR = 0.040; RMSEA = 0.061 (90% CI 0.054–0.069), and in the group of men: CFI = 0.987; TLI = 0.982; SRMR = 0.039; RMSEA = 0.047 (90% CI 0.012–0.073). Next, four different models of measurement invariance were explored. The results are presented in Table 9. The comparison of the configural and metric measurement invariance indicated that the added constraint did not significantly lessen the goodness of fit (ΔCFI = 0.000; ΔSRMR = 0.002; ΔRMSEA = 0.003; Δχ = 16.67). Second, the comparison between models 3 and 2 showed that the additional constraint did not significantly weaken the fit (ΔCFI = 0.002; ΔSRMR = 0.001; ΔRMSEA = 0.001; Δχ = 30.15, p < 0.001). Lastly, the comparison of models 4 and 3 also revealed that the added constraint did not significantly alter the fit (ΔCFI = 0.000; ΔSRMR = 0.001; ΔRMSEA = 0.003; Δχ = 6.79). These results support the hypothesis of cross-gender measurement invariance of the WEL.

3.2.4. Reliability and sensibility of the WEL

The intra-class coefficient (ICC), calculated between the even and odd items, with a Spearman-Brown correction, was equal to 0.87. Cronbach’s alpha coefficient was 0.88 for the “External stimuli” dimension, 0.90 for the “Internal stimuli” dimension and 0.91 for the whole scale. These indices indicate a satisfactory internal consistency of the scale. A good sensibility of the scale was supported by a satisfactory Ferguson’s delta coefficient (δ = 0.99) and a good discrimination analysis of the items with a discrimination index superior to 0.40 for all the items. In conclusion, these results endorse satisfactory reliability and sensibility of the French validation of the WEL.

3.2.5. Relationships with sociodemographic and psychological variables

Given the fact that the data were not distributed normally (Mardia coefficient: | z | > 5, Shapiro normality test: p < 0.001), nonparametric Spearman rhô correlation coefficients were used in order to examine the links between the variables. The correlation coefficient values are displayed in Table 10.

Table 10

Correlations between measured variables: Results from study 2.

	1.	2.	3.	4.	5.	6.	7.	8.	9.	10.	11.
1. Agea	-
2. BMIa	-0.05	-
3. WELa	0.05*	-0.05	-
4. WEL-ISa	0.06**	-0.08**	0.88***	-
5. WEL-ESa	0.03	0	0.87***	0.53***	-
6. SSESa	0.12***	-0.02	0.47***	0.44***	0.38***	-
7. SSES-Sa	0.22***	0	0.23***	0.22***	0.18***	0.64***	-
8. SSES-Pa	-0.02	0.04	0.40***	0.36***	0.34***	0.79***	0.21***	-
9. SSES-Aa	0.1***	-0.11***	0.38***	0.38***	0.28***	0.74***	0.30***	0.38***	-
10. PSS-11a	-0.06**	0.02	-0.46***	-0.46***	-0.35***	-0.56***	-0.27***	-0.55***	-0.37***	-
11.WHO-5a	0.03	-0.02	0.40***	0.41***	0.29***	0.53***	0.18***	0.52***	0.42***	-0.65***	-
12. MDIb	0.05	-0.02	-0.28***	-0.26***	-0.22***	-0.51***	-0.22***	-0.52***	-0.29***	0.55***	-0.64***

Note.

= Total sample (N = 1737)

= participants who responded to the MDI (n = 967); BMI = Body Mass Index; WEL = Weight Efficacy Life-Style Questionnaire; WEL–IS = Internal Stimuli; WEL–ES = External Stimuli; SSES = State Self-Esteem Scale; SSES–S = State Self-Esteem–Social scale; SSES–P = State Self-Esteem–Performance scale; SSES–A = State Self-Esteem–Appearance scale; PSS-11 = Perceived Stress Scale; WHO-5 = World Health Organization Well-Being index; MDI = Major Depression Inventory.

* p<0.05

** p<0.01

*** p<0.001.

Age was positively but weakly correlated with the total WEL score (rhô = 0.05) and its “Internal stimuli” subscale (rhô = 0.06). BMI was negatively correlated with the “Internal stimuli” subscale only (rhô = -0.08). The total WEL score and its two subscales were strongly correlated with each other. They also displayed identical correlation pattern with other variables. The total WEL score and the two subscales were positively correlated with the total SSES score (rhô = 0.47; rhô = 0.44 and rhô = 0.38, respectively) and its three subscales “Social” (rhô = 0.23; rhô = 0.22 and rhô = 0.18, respectively), “Performance” (rhô = 0.40; rhô = 0.36 and rhô = 0.34, respectively) and “Appearance” (rhô = 0.38 and rhô = 0.28). Additionally, they were positively correlated to the WHO-5 scale (rhô = 0.40; rhô = 0.41 and rhô = 0.29, respectively). On the other hand, negative correlations were observed between the total WEL score, “Internal stimuli” and “External stimuli” subscales and the PSS-11 (rhô = -0.46 and rhô = -0.35) and MDI scores (rhô = -0.28; rhô = -0.26 and rhô = -0.22, respectively).

Since the data were not distributed normally, non-parametric Kruskall-Wallis and Wilcoxon–Mann–Whitney U tests were used for mean comparison analyses. The results are displayed in Table 11. Significant differences of WEL scores were observed between the four BMI categories. Participants in Category III obesity had the lowest WEL scores when compared to Overweight participants or Category I obesity (p = 0.026). However, the size effect of these differences was extremely small (η2 = 0.005). Likewise, when compared to the other three BMI categories, participants in category III obesity had the lowest eating self-efficacy towards internal stimuli (p < 0.05) but the size effect of these differences was also very small (η2 = 0.008).

Table 11

Means, standard deviations, Wilcoxon–Mann–Whitney and Kruskall-Wallis statistics for study 2 variables.

	Female	Male		Overweight	Category I obesity	Category II	Category III obesity
				(n = 710)
					(n = 581)	obesity (n = 265)	(n = 181)
	(n = 1427)	(n = 310)
Variable	M (SD)	M (SD)	U (1, 1735)	M (SD)	M (SD)	M (SD)	M (SD)	χ2 (3)	η 2
BMIa	32.26 (5.63)	32.47 (5.59)	9199	27.50 (1.42)	32.21 (1.45)	37.16 (1.37)	44.25 (1.33)	1544.4***	0.88
Agea	44.4 (11.26)	44.64 (11.19)	217560	45.20 (11.11)	44.00 (11.48)	43.71 (11.31)	43.97 (10.84)	5.415
WELa	58.49 (20.64)	59.33 (20.15)	217556	59.00 (20.59)	59.23 (20.18)	59.26 (21.15)	54.39 (20.51)	9.27*	0.005
WEL–ISa	24.27 (12.04)	24.84 (11.89)	215583	24.97 (11.87)	24.59 (12.00)	24.32 (12.03)	21.36 (12.23)	13.066**	0.008
WEL–ESa	34.22 (11.62)	34.49 (11.02)	219442	34.03 (11.66)	34.64 (11.14)	34.94 (11.85)	33.03 (11.61)	3.66
SSESa	43.49 (9.53)	44.95 (9.49)	206266.	44.03 (9.46)	44.49 (9.71)	44.39 (9.52)	42.92 (9.21)	1.334 c
SSES–Sa	10.91 (3.79)	11.21 (3.70)	209931	10.84 (3.85)	11.17 (3.72)	10.90 (3.67)	10.91 (3.79)	2.96
SSES–Pa	25.08 (5.28)	25.39 (5.36)	213725	24.79 (5.26)	25.37 (5.28)	25.68 (5.20)	24.96 (5.56)	8.05.
SSES–Aa	7.95 (3.92)	8.35 (3.95)	206888.	8.41 (4.02)	7.95 (3.89)	7.81 (4.00)	7.06 (3.36)	20.21***	0.01
PSS-11a	31.65 (7.87)	31.04 (7.82)	230984	31.96 (7.82)	30.86 (7.81)	30.90 (7.60)	32.99 (8.34)	13.149**	0.008
WHO-5a	51.24 (23.06)	53.39 (22.55)	215230	50.81 (23.29)	52.53 (22.43)	52.51 (22.55)	48.91 (23.84)	4.94
	Female	Male		Overweight	Category I obesity	Category II obesity	Category III obesity
				(n = 410)
					(n = 313)	(n = 136)	(n = 108)
	(n = 797)	(n = 170)
Variable	M (SD)	M (SD)	U (1,965)	M (SD)	M (SD)	M (SD)	M (SD)	χ2 (3)	η 2
MDIb	23.56 (8.85)	22.69 (8.36)	71550	13.82 (13.59)	12.23 (13.11)	11.65 (12.89)	14.51 (13.51)	9.098**	0.006

Note.

= Total sample (n = 1737)

= participants that responded to the MDI scale (n = 967); = result obtained with ANOVA (F(3, 1733)), because the SSES distribution was normal; WEL = Weight Efficacy Life-Style Questionnaire; WEL–IS = Internal Stimuli; WEL–ES = External Stimuli; SSES = State Self-Esteem Scale; SSES–S = State Self-Esteem–Social scale; SSES–P = State Self-Esteem–Performance scale; SSES–A = State Self-Esteem–Appearance scale; PSS-11 = Perceived Stress Scale; WHO-5 = World Health Organization Well-Being index; MDI = Major Depression Inventory; BMI = Body Mass Index. p<0.1

* p<005

** p<0.01

*** p<0.001.

3.3. Discussion

Our findings indicate that the French 11-item version of the WEL (WEL-Fr-C) can be administered to a clinical population of adults suffering from obesity, regardless of their BMI. Good psychometric properties and the established measurement invariance of the WEL-Fr-C endorse the idea that it is a valid instrument for assessing self-efficacy for controlled eating in both men and women from a clinical group. Results from mean comparisons and correlation analyses help improve the description of characteristics and difficulties present in a clinical population and related to eating self-efficacy.

4. Discussion

The aim of this research was to validate the French version of the Weight Efficacy Life-Style questionnaire in general population and clinical samples, to explore the psychometric properties of the scale, its measurement invariance as well as the relationships with other variables included in the two studies. Exploratory and confirmatory factor analyses yielded a two-factor structure of the scale for each of the samples, but provided two different French versions of WEL with specific items: 12 items in the general population sample (items: 1, 3, 4, 6, 8, 11, 12, 13, 14, 16, 18 and 19; WEL-Fr-G) and 11 items in the clinical sample (items: 1, 3, 6, 7, 8, 11, 12, 13, 16, 18 and 19; WEL-Fr-C). Compared to the original scale [39], which embodies 20 items and three factors, the factorial structure and the number of items are different in the two French versions. For WEL-Fr-G, items belonging to the Positive Activities subscale from the original version (items 5, 10, 15 and 20) were completely removed, along with items 2, 7 and 17 from the Availability scale and item 9 from the Physical Discomfort scale. For WEL-Fr-C, the same items were removed with the exception of item 7, which was kept and items 4 and 14 (from the original Physical Discomfort scale), which were removed. The English WEL-SF [78] and its Norwegian version [74] share several removed items with the French versions: items 9, 10, 15, 17 and 20. However, no statistical parameter can explain the removal of items 2, 4 and 5 from the French versions. Therefore, their withdrawal may be due to the ambiguity of their content in French.

The reliability analysis of the two versions of the French WEL validation revealed a strong internal consistency, according to the Cronbach’s alpha coefficients and ICC. For the WEL-Fr-G, α = 0.91 for the general score and ICC = 0.92; α = 0.90 for the “External stimuli” scale and α = 0.91 for the “Internal stimuli” scale. For the WEL-Fr-C, α = 0.91 for the general score and ICC = 0.86; α = 0.88 for the “External stimuli” scale and α = 0.90 for the “Internal stimuli” scale. These values are similar to those declared in other validations and adaptations of the WEL, with alpha values ranging from 0.78 to 0.92 [39, 74, 78, 81]. In addition to a strong reliability, the French version of the scale presented satisfactory sensibility as well. Moreover, measurement invariance analysis revealed that WEL-Fr-C can be used in a clinical sample regardless of participants’ gender or BMI.

Body Mass Index was negatively correlated with the general score of WEL-Fr-G and WEL-Fr-C and the two subscales of WEL-Fr-G. For WEL-Fr-C, only “Internal stimuli” scale displayed significant negative correlation with BMI. These results are in line with previous studies which reported negative correlations between ESE and BMI [22, 40, 47, 51, 63, 65, 68, 72, 73]. Contrary to the results presented by Ames, Heckman, Diehl, Grothe and Clark [68], age was positively correlated with the general score of WEL-Fr and the “Internal stimuli” subscale of WEL-Fr-C. In both the general and the clinical samples, ESE was positively correlated with the self-esteem and well-being and negatively correlated with perceived stress and depressive symptoms. These results corroborate those from previous studies [55, 62, 63, 67–69]. However, a few differences were observed when comparing the correlation coefficients of the two subscales of the French WEL and the other variables in the two samples: for WEL-Fr-G, the “External stimuli” subscale displayed stronger links with Appearance self-esteem, well-being and perceived stress than the “Internal stimuli” subscale. Conversely, for WEL-Fr-C, the “Internal stimuli” subscale displayed stronger correlations with Appearance self-esteem, well-being and perceived stress than the “External stimuli” subscale. We can suppose that, in a general population, eating self-efficacy when faced with external stimuli is more predictive of impairment and a state of well-being than self-efficacy in the context of internal stimuli. Accordingly, in a clinical sample, eating self-efficacy in the context of internal stimuli may be more predictive of impairment and a state of well-being, than self-efficacy in the context of external stimuli. Significant differences in eating self-efficacy tendencies were observed in both samples according to the BMI category. Participants in the “Underweight” BMI category had higher eating self-efficacy scores than those in the “Normal weight” category. Likewise, participants in “Category III obesity” reported the lowest levels of eating self-efficacy when compared to the other three BMI categories. Similar differences were reported in a study by Menéndez-González and Orts-Cortés [72]. However, as in the studies by Ames et al. [68] and Clark and King [58], no significant differences were observed in eating self-efficacy trends by gender in either sample.

This research carries some limits. Because of uneven and small samples of men and underweight participants, mean comparison tests as well as cross-BMI and cross-gender measurement invariance will need to be confirmed in larger general population samples. Also, the cross-sectional design of the study made it impossible to explore the test-retest reliability of the two versions of the French WEL scale as well as to identify the predictors of ESE. Future studies using a longitudinal design are needed to identify these predictors. Given the fact that eating self-efficacy plays an important role in various health behaviours and in different process related to weight loss and its maintenance (adherence to a new behaviour, early withdrawal, relapse, etc.), future studies could focus on creating comprehensive and predictive models of weight loss and weight maintenance incorporating eating and weight related self-efficacy. Moreover, only one study explored a link between ESE and calorie restriction diet in a general population [40]. It could be interesting to explore the nature of the links between ESE and intermittent fasting in a general population, not seeking to lose weight. Furthermore, some studies explored the links between ESE and eating disorders. They reported negative correlations between the WEL score and binge eating disorder [64, 69, 99] as well as some symptoms of eating disorders as measured by the EDI-2 [64] and EAT-26 [65]. Links with ESE, eating disorders and different eating styles remain to be investigated. Moreover, to our knowledge, only one study explored the links between orthorexia nervosa and general self-efficacy [100]. The authors found that the cluster of participants that had the healthiest diet also had the greatest general self-efficacy scores. Those participants also had higher orthorexic tendencies, which are described as the pathological obsession for healthy food [101]. Therefore, the following studies could also explore the negative consequences of high levels of eating-self efficacy, especially in the context of orthorexia nervosa.

The use of the French version of the WEL can contribute to a better evaluation of eating behaviours in diverse populations, both general and clinical. The application of the two versions of the scale is not exclusive to mental health professionals: it can be used by physicians with patients whose treatment includes diet adjustments. The results of our study highlight the important role that psychological factors play in individuals with normal weight, but also in patients with obesity. Multidisciplinary interventions have been shown to be effective for weight loss or a disease management that includes diet adjustment. Therefore, nutritional interventions should take into account the psychological factors related to eating behaviour. Although we emphasize multidisciplinary interventions on weight loss in adults with obesity by taking into account biological, psychological, and social factors, we are aware that such actions are sometimes difficult to implement. Too often, obesity treatment focus on dietary changes and the promotion of physical activity. In addition, research on psychological factors do not systematically examine general and eating self-efficacy.

5. Conclusions

Based on the results from this research, two different versions of the WEL should be used: the WEL-Fr-G for the assessment of ESE in the general French population and the WEL-Fr-C for a use in a clinical population. The results from this research suggest that the two French versions of the WEL are psychometrically sound instruments for assessing self-efficacy for controlled eating. Further studies will be necessary to explore eating self-efficacy in different contexts and different populations (individuals suffering from eating disorders, chronic diseases, individuals who are fasting intermittently etc.) and its links with specific eating behaviours or disorders.

26 Jul 2021

PONE-D-21-08991

French validation of the Weight Efficacy Life-Style questionnaire (WEL): Links with mood, self-esteem and stress among the general population and a clinical sample of individuals with overweight and obesity

PLOS ONE

Dear Dr. Plasonja,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 09 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Antonio Palazón-Bru, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

3. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

4. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research

5. Thank you for stating the following in the Acknowledgments Section of your manuscript:

The authors would like to give special thanks to Michel Dubourdeaux (R&D Innovation Director at PiLeJe), Christophe Guyomar (Chief Digital Officer at PiLeJe) for their administrative and technical support and Claude Blondeau (Head of Scientific Communication at PiLeJe) for editing the manuscript. Thanks are also addressed to Dr Dominique Périn Calvão for the translation of the MDI, Dr Marilou Bruchon-Schweitzer, Dr Eve Villemur and Dr Gérard Ostermann for their contribution to the translation of the WEL and SSES scales. Anna Brytek-Matera acknowledges financial support by the „Excellence Initiative – Research University” program for years 2020-2026 of the University of Wroclaw.

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

Anna Brytek-Matera acknowledges financial support by the „Excellence Initiative – Research University” program for years 2020-2026 of the University of Wroclaw.

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

6. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Dr,

I have gone through the manuscript and feel the manuscript was well written by the authors in this work on French validation of the Weight Efficacy Life-Style questionnaire (WEL): Links with mood, self-esteem and stress among the general population and a clinical sample of individuals with overweight and obesity. However, a minor revision is needed to improve the quality of this paper.

Abstract: In the design, the authors mentioned multiple statistical analyses. Please report the most important/significant; this will improve the result section, which in the current version is ard to understand where the major benefits happened.

Introduction:

Please clarify following question into Introduction section:

• What is the main question addressed by the research?

• How original is the topic? What does it add to the subject area compared with other published material?

• Please show the gap clearly. What is already known and what new knowledge this work will provide?

Discussion:

What are the policy implications of these findings? How can your findings inform improvements in existing nutritional interventions? What is the barrier to incorporating its use in public health?

If a public health manager wants to scale up this intervention, would this be feasible?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

29 Sep 2021

Manuscript PONE-D-21-08991

Response to Reviewers

Dear Dr. Palazón-Bru,

Thank you for giving us the opportunity to submit a revised draft of the manuscript “French validation of the Weight Efficacy Life-Style questionnaire (WEL): Links with mood, self-esteem and stress among the general population and a clinical sample of individuals with overweight and obesity” for publication in the PLOS ONE journal.

We appreciate the time and effort that you and the reviewer dedicated to providing feedback on our manuscript and are grateful for the insightful comments on and valuable improvements to our paper.

We have incorporated all the suggestions made by the reviewer. Those changes are highlighted in red within the document named “Revised Manuscript with track Changes”.

Please see below, in blue, for a point-by-point response to the reviewers’ comments and concerns. All line numbers refer to the revised manuscript file with tracked changes.

Sincerely,

Natalija Plasonja

PhD student at the University of Bordeaux, France

natalija.plasonja@u-bordeaux.fr

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response: The style requirements of the manuscript have been verified.

2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response: Thank you for pointing this out. All the references were converted to the “Vancouver” style.

3. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

4. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

Response: Thank you for the reminder. Information regarding the informed consent of patients and their legal representative are included in the Methods section, 2.1.1. ESTEAM cohort (lines 173-180).

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research

Response: Thank you for pointing this out. Information regarding the anonymization of the data have been integrated in the Methods section, 2.1.1. ESTEAM cohort (lines 173-180).

5. Thank you for stating the following in the Acknowledgments Section of your manuscript:

The authors would like to give special thanks to Michel Dubourdeaux (R&D Innovation Director at PiLeJe), Christophe Guyomar (Chief Digital Officer at PiLeJe) for their administrative and technical support and Claude Blondeau (Head of Scientific Communication at PiLeJe) for editing the manuscript. Thanks are also addressed to Dr Dominique Périn Calvão for the translation of the MDI, Dr Marilou Bruchon-Schweitzer, Dr Eve Villemur and Dr Gérard Ostermann for their contribution to the translation of the WEL and SSES scales. Anna Brytek-Matera acknowledges financial support by the „Excellence Initiative – Research University” program for years 2020-2026 of the University of Wroclaw.

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

Anna Brytek-Matera acknowledges financial support by the „Excellence Initiative – Research University” program for years 2020-2026 of the University of Wroclaw.

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Response: Thank you for pointing this out. The funding statement was removed from the Acknowledgments section and the manuscript and was added to the updated version of the cover letter, which was then completed with additional information regarding the funding of this research.

6. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

Response: The full ethics statement was added in the Methods section, 2.1.1. ESTEAM cohort (lines 173-180).

[Note: HTML markup is below. Please do not edit.]

Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Dr,

I have gone through the manuscript and feel the manuscript was well written by the authors in this work on French validation of the Weight Efficacy Life-Style questionnaire (WEL): Links with mood, self-esteem and stress among the general population and a clinical sample of individuals with overweight and obesity. However, a minor revision is needed to improve the quality of this paper.

Response: Thank you very much.

Abstract: In the design, the authors mentioned multiple statistical analyses. Please report the most important/significant; this will improve the result section, which in the current version is hard to understand where the major benefits happened.

Response: Thank you for your comment. Your suggestion was taken into account and the abstract was revised accordingly (lines 31-36).

Introduction:

Please clarify following question into Introduction section:

• What is the main question addressed by the research?

Response: Thank you for pointing this out. The main question addressed by the research has been made clearer at the end of the Introduction section (lines 142-147).

• How original is the topic? What does it add to the subject area compared with other published material?

Response: This suggestion has been taken into account and additional information has been provided (lines 142-147).

• Please show the gap clearly. What is already known and what new knowledge this work will provide?

Response: Thank you for your suggestion. Additional information has been included in the Introduction section (lines 142-147).

Discussion:

What are the policy implications of these findings?

Response: Our findings may feed into the formulation of the national health policy and strategies in obesity prevention and intervention efforts. This idea has briefly been addressed at the beginning of the last paragraph of the Discussion (lines 674 – 677).

How can your findings inform improvements in existing nutritional interventions?

What is the barrier to incorporating its use in public health?

Response: These two questions have been addressed in the last paragraph of the Discussion (lines 674 – 683).

If a public health manager wants to scale up this intervention, would this be feasible?

Response: The public health manager needs a multidisciplinary team for creating and implementing the nutritional intervention.

Submitted filename: Response to Reviewers.docx

Click here for additional data file.

29 Oct 2021

French validation of the Weight Efficacy Life-Style questionnaire (WEL): Links with mood, self-esteem and stress among the general population and a clinical sample of individuals with overweight and obesity

PONE-D-21-08991R1

Dear Dr. Plasonja,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Antonio Palazón-Bru, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is an interesting study and the authors have collected a unique dataset using appropriate methodology. The paper is generally well written and structured. The authors replied to all comments well. So, this manuscript can be accepted for publication in this journal.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

5 Nov 2021

PONE-D-21-08991R1

French validation of the Weight Efficacy Life-Style questionnaire (WEL): Links with mood, self-esteem and stress among the general population and a clinical sample of individuals with overweight and obesity

Dear Dr. Plasonja:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Antonio Palazón-Bru

Academic Editor

PLOS ONE